Assenagon Asset Management S.A.
Position in TVTX — Travere Therapeutics, Inc.
CIK 1546007
SENNINGERBERG, N4
Position in TVTX
as of Jun 30, 2026
· filed Aug 21, 2026
Position Value
$24,275,197
+$24,039,686 QoQ
Shares Held
427,305
+5290.5% QoQ
Ownership
0.453%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#47
of 317 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TVTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Assenagon Asset Management S.A. holds $1,940,218,245 across 69 Biotechnology names. TVTX ranks #20 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
759,564 | $377,298,225 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
8,362,952 | $295,964,871 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
244,927 | $152,721,781 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
454,682 | $111,292,513 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
1,762,086 | $100,826,560 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
997,643 | $78,085,517 | |
| 7 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
124,214 | $66,696,707 | |
| 8 | TARS |
Tarsus Pharmaceuticals, Inc.
|
947,495 | $59,635,335 |
All Filings in TVTX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $24,275,197 | 427,305 | Shares | Sole | 2026-08-21 | |
| 2026-03-31 | $235,511 | 7,927 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $15,961,921 | 417,742 | Shares | Sole | 2026-01-09 | |
| 2025-09-30 | $2,231,184 | 93,355 | Shares | Sole | 2025-10-07 | |
| 2025-06-30 | $16,325,510 | 1,103,075 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $7,410,170 | 413,514 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $9,241,536 | 530,513 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $19,229,562 | 1,374,522 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $18,199,893 | 2,214,099 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $1,686,022 | 218,680 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $2,283,918 | 254,051 | Shares | Sole | 2024-01-17 | |
| 2023-09-30 | $2,271,215 | 254,051 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $16,865,971 | 1,098,045 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $37,303,915 | 1,658,689 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $18,241,821 | 867,419 | Shares | Sole | 2023-01-12 | |
| 2022-09-30 | $22,780,024 | 924,514 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $23,029,766 | 950,465 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $8,023,515 | 311,351 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $6,069,282 | 195,531 | Shares | Sole | 2022-02-01 | |
| 2020-09-30 RTRX | — | 359,761 | Shares | Sole | 2020-10-07 | |
| 2020-06-30 RTRX | — | 164,169 | Shares | Sole | 2020-07-21 | |
| 2020-03-31 RTRX | — | 430,446 | Shares | Sole | 2020-04-17 | |
| No filing history on record for this holder in this stock. | ||||||